Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SkinDNA is an Australian genomics and personalized skincare diagnostics company focused on DNA-based assessment of skin aging risk and individualized skincare recommendations. Its flagship commercial product is the SkinDNA Genetic Test, which analyzes skin-related genetic markers and combines them with proprietary algorithms to generate reports covering categories such as firmness, wrinkling, sun damage, free radical damage, and sensitivity. The company also offers white-label and OEM genetic testing solutions for skincare brands and professionals. SkinDNA describes its business as combining genetic analysis, skin science, and clinical product recommendation rather than developing traditional therapeutic drug candidates. The company was acquired by Rayont in August 2022 but the SkinDNA brand and website remain active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SkinDNA.